[Uric acid, kidney disease and nephrolithiasis].

Area of Science:

• Nephrology
• Metabolic Diseases
• Toxicology

Context:

• Hyperuricemia is associated with diverse kidney diseases, including tumor lysis syndrome and chronic urate nephropathy.
• The etiology of chronic urate nephropathy remains debated, with potential links to chronic lead intoxication.
• Uric acid nephrolithiasis is primarily associated with urinary acidification defects, not solely hyperuricemia.

Purpose:

• To explore the varied pathophysiologic mechanisms of kidney diseases linked to hyperuricemia.
• To differentiate therapeutic approaches for acute renal failure in tumor lysis syndrome versus chronic urate nephropathy.
• To investigate the role of urinary acidification defects and associated metabolic diseases in uric acid nephrolithiasis.

Summary:

• Different kidney diseases present with hyperuricemia, necessitating tailored therapies.
• Tumor lysis syndrome causes acute renal failure due to rapid uric acid increase, while chronic urate nephropathy involves prolonged elevated uric acid.
• Chronic lead intoxication is a potential cause of chronic urate nephropathy.
• Uric acid stones are linked to urinary acidification defects and metabolic diseases with insulin resistance, requiring thorough patient evaluation.

Impact:

• Highlights the need for distinct diagnostic and therapeutic strategies for hyperuricemia-related kidney conditions.
• Suggests a re-evaluation of chronic urate nephropathy etiology, considering lead exposure.
• Emphasizes the importance of screening for metabolic diseases, particularly insulin resistance, in patients with uric acid kidney stones.